ReP USP - Resultado da busca

Artigo de periodico
Complete revascularization with multivessel PCI for myocardial infarction (2019)
Mehta, Shamir R; Wood, David A.; Storey, Robert F.; Mehran, Roxana; Bainey, Kevin R.; Nguyen, Helen; Meeks, Brandi; Di Pasquale, Giuseppe; López-Sendon, Jose; Marin Neto, José Antonio
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, REVASCULARIZAÇÃO MIOCÁRDICA, INFARTO DO MIOCÁRDIO, CONTENEDORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Shamir R et al. Complete revascularization with multivessel PCI for myocardial infarction. The New England Journal of Medicine, v. 380, n. 15, p. 1411-1421, 2019Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1907775. Acesso em: 02 maio 2026.
APA
Mehta, S. R., Wood, D. A., Storey, R. F., Mehran, R., Bainey, K. R., Nguyen, H., et al. (2019). Complete revascularization with multivessel PCI for myocardial infarction. The New England Journal of Medicine, 380( 15), 1411-1421. doi:10.1056/NEJMoa1907775
NLM
Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, López-Sendon J, Marin Neto JA. Complete revascularization with multivessel PCI for myocardial infarction [Internet]. The New England Journal of Medicine. 2019 ; 380( 15): 1411-1421.[citado 2026 maio 02 ] Available from: https://doi.org/10.1056/NEJMoa1907775
Vancouver
Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, López-Sendon J, Marin Neto JA. Complete revascularization with multivessel PCI for myocardial infarction [Internet]. The New England Journal of Medicine. 2019 ; 380( 15): 1411-1421.[citado 2026 maio 02 ] Available from: https://doi.org/10.1056/NEJMoa1907775
Artigo de periodico
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease (2016)
Bonaca, Marc P.; Bhatt, Deepak L.; Storey, Robert F.; Steg, Gabriel; Cohen, Marc; Kuder, Julia; Goodrich, Erica; Nicolau, José C.; Parkhomenko, Alexander; López-Sendón, José; Dellborg, Mikael; Dalby, Anthony; Špinar, Jindřich; Aylward, Philip; Corbalán, Ramón; Abola, Maria Teresa B.; Jensen, Eva C.; Held, Peter; Braunwald, Eugene; Sabatine Marc S.
Source: Journal of the American College of Cardiology. Unidade: FM
Subjects: PLACEBO, FÁRMACOS (SISTEMA CARDIOVASCULAR), DOENÇAS CARDIOVASCULARES, REVASCULARIZAÇÃO MIOCÁRDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONACA, Marc P. et al. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease. Journal of the American College of Cardiology, v. 67, n. 23, p. 2719-2728, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2016.03.524. Acesso em: 02 maio 2026.
APA
Bonaca, M. P., Bhatt, D. L., Storey, R. F., Steg, G., Cohen, M., Kuder, J., et al. (2016). Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease. Journal of the American College of Cardiology, 67( 23), 2719-2728. doi:10.1016/j.jacc.2016.03.524
NLM
Bonaca MP, Bhatt DL, Storey RF, Steg G, Cohen M, Kuder J, Goodrich E, Nicolau JC, Parkhomenko A, López-Sendón J, Dellborg M, Dalby A, Špinar J, Aylward P, Corbalán R, Abola MTB, Jensen EC, Held P, Braunwald E, Sabatine Marc S. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease [Internet]. Journal of the American College of Cardiology. 2016 ; 67( 23): 2719-2728.[citado 2026 maio 02 ] Available from: https://doi.org/10.1016/j.jacc.2016.03.524
Vancouver
Bonaca MP, Bhatt DL, Storey RF, Steg G, Cohen M, Kuder J, Goodrich E, Nicolau JC, Parkhomenko A, López-Sendón J, Dellborg M, Dalby A, Špinar J, Aylward P, Corbalán R, Abola MTB, Jensen EC, Held P, Braunwald E, Sabatine Marc S. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease [Internet]. Journal of the American College of Cardiology. 2016 ; 67( 23): 2719-2728.[citado 2026 maio 02 ] Available from: https://doi.org/10.1016/j.jacc.2016.03.524
Artigo de periodico
Long-term use of ticagrelor in patients with prior myocardial infarction (2015)
Bonaca, Marc P.; Bhatt, Deepak L.; Cohen, Marc; Steg, Philippe Gabriel; Storey, Robert F.; Jensen, Eva C.; Magnani, Giulia; Bansilal, Sameer; Fish, M. Polly; Im, Kyungah; Bengtsson, Olof; Ophuis, Ton Oude; Budaj, Andrzej; Theroux, Pierre; Ruda, Mikhail; Hamm, Christian; Goto, Shinya; Spinar, Jindrich; Nicolau, José Carlos; Kiss, Robert G.; Murphy, Sabina A.; Wiviott, Stephen D.; Held, Peter; Braunwald, Eugene; Sabatine, Marc S.; Marin Neto, José Antonio
Source: The New England Journal of Medicine. Unidades: FM, FMRP
Subjects: FATORES DE RISCO, INFARTO DO MIOCÁRDIO, ADESÃO À MEDICAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONACA, Marc P. et al. Long-term use of ticagrelor in patients with prior myocardial infarction. The New England Journal of Medicine, v. 372, n. 19, 2015Tradução . . Disponível em: http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260. Acesso em: 02 maio 2026.
APA
Bonaca, M. P., Bhatt, D. L., Cohen, M., Steg, P. G., Storey, R. F., Jensen, E. C., et al. (2015). Long-term use of ticagrelor in patients with prior myocardial infarction. The New England Journal of Medicine, 372( 19). doi:10.1056/NEJMoa1500857
NLM
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS, Marin Neto JA. Long-term use of ticagrelor in patients with prior myocardial infarction [Internet]. The New England Journal of Medicine. 2015 ; 372( 19):[citado 2026 maio 02 ] Available from: http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260
Vancouver
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS, Marin Neto JA. Long-term use of ticagrelor in patients with prior myocardial infarction [Internet]. The New England Journal of Medicine. 2015 ; 372( 19):[citado 2026 maio 02 ] Available from: http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260
Artigo de periodico
The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial (2014)
Husted, Steen; James, Stefan K.; Bach, Richard G.; Becker, Richard C.; Budaj, Andrzej; Heras, Magda; Himmelmann, Anders; Horrow, Jay; Katus, Hugo A.; Lassila, Riita; Morais, Joao; Nicolau, José C.; Steg, Gabriel; Storey, Robert F.; Wojdyla, Daniel; Wallentin, Lars
Source: European heart journal. Unidade: FM
Subjects: TROMBOSE, SEXO, SÍNDROME CORONARIANA AGUDA, PLAQUETAS SANGUÍNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUSTED, Steen et al. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. European heart journal, v. 35, n. 23, p. 1541-1550, 2014Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehu075. Acesso em: 02 maio 2026.
APA
Husted, S., James, S. K., Bach, R. G., Becker, R. C., Budaj, A., Heras, M., et al. (2014). The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. European heart journal, 35( 23), 1541-1550. doi:10.1093/eurheartj/ehu075
NLM
Husted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, Himmelmann A, Horrow J, Katus HA, Lassila R, Morais J, Nicolau JC, Steg G, Storey RF, Wojdyla D, Wallentin L. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial [Internet]. European heart journal. 2014 ; 35( 23): 1541-1550.[citado 2026 maio 02 ] Available from: https://doi.org/10.1093/eurheartj/ehu075
Vancouver
Husted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, Himmelmann A, Horrow J, Katus HA, Lassila R, Morais J, Nicolau JC, Steg G, Storey RF, Wojdyla D, Wallentin L. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial [Internet]. European heart journal. 2014 ; 35( 23): 1541-1550.[citado 2026 maio 02 ] Available from: https://doi.org/10.1093/eurheartj/ehu075
Artigo de periodico
Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study (2013)
Kohli, Payal; Wallentin, Lars; Reyes, Eric; Horrow, Jay; Husted, Steen; Angiolillo, Dominick J.; Ardissino, Diego; Maurer, Gerald; Morais, Joao; Nicolau, José C.; Oto, Ali; Storey, Robert F.; James, Stefan K.; Cannon, Christopher P.
Source: Circulation. Unidade: FM
Subjects: REVASCULARIZAÇÃO MIOCÁRDICA, DOENÇA AGUDA, INFARTO DO MIOCÁRDIO, COMORBIDADE, CHOQUE CARDIOGÊNICO, FATORES DE RISCO, ISQUEMIA, REVIDIVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOHLI, Payal et al. Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study. Circulation, v. 127, n. 6, p. 673-680, 2013Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.112.124248. Acesso em: 02 maio 2026.
APA
Kohli, P., Wallentin, L., Reyes, E., Horrow, J., Husted, S., Angiolillo, D. J., et al. (2013). Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study. Circulation, 127( 6), 673-680. doi:10.1161/CIRCULATIONAHA.112.124248
NLM
Kohli P, Wallentin L, Reyes E, Horrow J, Husted S, Angiolillo DJ, Ardissino D, Maurer G, Morais J, Nicolau JC, Oto A, Storey RF, James SK, Cannon CP. Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study [Internet]. Circulation. 2013 ; 127( 6): 673-680.[citado 2026 maio 02 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.112.124248
Vancouver
Kohli P, Wallentin L, Reyes E, Horrow J, Husted S, Angiolillo DJ, Ardissino D, Maurer G, Morais J, Nicolau JC, Oto A, Storey RF, James SK, Cannon CP. Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study [Internet]. Circulation. 2013 ; 127( 6): 673-680.[citado 2026 maio 02 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.112.124248
Artigo de periodico
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial (2011)
Held, Claes; Åsenblad, Nils; Bassand, Jean Pierre; Becker, Richard C.; Cannon, Christopher P.; Claeys, Marc J.; Harrington, Robert A.; Horrow, Jay; Husted, Steen; James, Stefan K.; Mahaffey, Kenneth W.; Nicolau, José C.; Scirica, Benjamin M.; Storey, Robert F.; Vintila, Marius; Ycas, Joseph; Wallentin, Lars
Source: Journal of the American College of Cardiology. Unidade: FM
Subjects: CORONARIOPATIA (CIRURGIA;TERAPIA), DOENÇA AGUDA, CONDUTAS TERAPÊUTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HELD, Claes et al. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial. Journal of the American College of Cardiology, v. 57, n. 6, p. 672-684, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2010.10.029. Acesso em: 02 maio 2026.
APA
Held, C., Åsenblad, N., Bassand, J. P., Becker, R. C., Cannon, C. P., Claeys, M. J., et al. (2011). Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial. Journal of the American College of Cardiology, 57( 6), 672-684. doi:10.1016/j.jacc.2010.10.029
NLM
Held C, Åsenblad N, Bassand JP, Becker RC, Cannon CP, Claeys MJ, Harrington RA, Horrow J, Husted S, James SK, Mahaffey KW, Nicolau JC, Scirica BM, Storey RF, Vintila M, Ycas J, Wallentin L. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial [Internet]. Journal of the American College of Cardiology. 2011 ; 57( 6): 672-684.[citado 2026 maio 02 ] Available from: https://doi.org/10.1016/j.jacc.2010.10.029
Vancouver
Held C, Åsenblad N, Bassand JP, Becker RC, Cannon CP, Claeys MJ, Harrington RA, Horrow J, Husted S, James SK, Mahaffey KW, Nicolau JC, Scirica BM, Storey RF, Vintila M, Ycas J, Wallentin L. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial [Internet]. Journal of the American College of Cardiology. 2011 ; 57( 6): 672-684.[citado 2026 maio 02 ] Available from: https://doi.org/10.1016/j.jacc.2010.10.029

USP Schools

ReP

Filtros

Authors

Date published

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration